SCHEMBL33526529

SCHEMBL33526529

Cc1nc(Cl)c(F)cc1C#N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KHK P50053 1/20 0.53
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 3/20 0.40
TRPV4 Q9HBA0 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
CYP11B2 P19099 5/20 0.36
CYP11B1 P15538 4/20 0.36
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
IDH1 O75874 2/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
XBP1 P17861 1/20 0.34
MAPK1 P28482 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6050497 0.85 KHK (0.62) KHKCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL12143428 0.82 KHK (0.44) KHKCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL29448447 0.82 KHK (0.69) KHKCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL29448448 0.82 KHK (0.69) KHKCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL165776 0.82 KHK (0.69) KHKCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL33526375 0.82 NPSR1 (0.59) KHKCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL11387117 0.80 NPSR1 (0.49) KHKCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL20620010 0.80 NPSR1 (0.49) KHKCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL23860801 0.77 KHK (0.73) KHKALDH1A1KDM4ETRPV4SMN1; SMN2
SCHEMBL20599441 0.77 NPSR1 (0.46) KHKCYP1A2CYP2C9CYP2C19NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260091048-A1 GIP RECEPTOR AGONIST COMPOUNDS LILLY CO ELI (US) 2026-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260091048-A1 GIP RECEPTOR AGONIST COMPOUNDS GIPR, GLP1R, GPR119 KHK 3253/4885CYP1A2 2194/4885CYP2C9 1804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.